Stifel Financial Corp Increases Holdings in Medidata Solutions, Inc. (MDSO)
Stifel Financial Corp raised its stake in Medidata Solutions, Inc. (NASDAQ:MDSO) by 222.4% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 205,852 shares of the company’s stock after acquiring an additional 142,011 shares during the period. Stifel Financial Corp owned approximately 0.35% of Medidata Solutions worth $16,126,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Alps Advisors Inc. increased its holdings in Medidata Solutions by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 8,430 shares of the company’s stock valued at $659,000 after acquiring an additional 22 shares during the last quarter. World Asset Management Inc increased its holdings in Medidata Solutions by 1.2% in the 2nd quarter. World Asset Management Inc now owns 3,528 shares of the company’s stock valued at $276,000 after acquiring an additional 43 shares during the last quarter. State Board of Administration of Florida Retirement System increased its holdings in Medidata Solutions by 0.3% in the 2nd quarter. State Board of Administration of Florida Retirement System now owns 33,828 shares of the company’s stock valued at $2,645,000 after acquiring an additional 109 shares during the last quarter. Pinebridge Investments L.P. increased its holdings in Medidata Solutions by 2.1% in the 2nd quarter. Pinebridge Investments L.P. now owns 7,305 shares of the company’s stock valued at $572,000 after acquiring an additional 153 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan increased its holdings in Medidata Solutions by 1.6% in the 1st quarter. Municipal Employees Retirement System of Michigan now owns 12,470 shares of the company’s stock valued at $719,000 after acquiring an additional 200 shares during the last quarter. Institutional investors own 97.52% of the company’s stock.
Medidata Solutions, Inc. (NASDAQ MDSO) traded down 0.65% during mid-day trading on Friday, hitting $78.06. 528,438 shares of the stock were exchanged. The stock’s 50 day moving average is $74.60 and its 200 day moving average is $70.33. The stock has a market cap of $4.42 billion, a PE ratio of 126.11 and a beta of 1.81. Medidata Solutions, Inc. has a 52-week low of $46.10 and a 52-week high of $85.92.
Medidata Solutions (NASDAQ:MDSO) last issued its earnings results on Tuesday, July 18th. The company reported $0.31 EPS for the quarter, beating the Zacks’ consensus estimate of $0.28 by $0.03. The business had revenue of $137.41 million during the quarter, compared to analysts’ expectations of $134.28 million. Medidata Solutions had a net margin of 7.07% and a return on equity of 11.14%. The company’s quarterly revenue was up 19.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.24 earnings per share. Analysts forecast that Medidata Solutions, Inc. will post $1.29 EPS for the current fiscal year.
In other news, COO Michael L. Capone sold 5,000 shares of the stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $74.53, for a total value of $372,650.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 5.80% of the stock is owned by corporate insiders.
A number of analysts have issued reports on the stock. Jefferies Group LLC reiterated a “hold” rating and issued a $78.00 price target on shares of Medidata Solutions in a report on Tuesday, August 22nd. Zacks Investment Research upgraded shares of Medidata Solutions from a “sell” rating to a “hold” rating in a report on Wednesday, September 20th. Morgan Stanley set a $74.00 price target on shares of Medidata Solutions and gave the company a “buy” rating in a report on Wednesday, June 14th. Royal Bank Of Canada assumed coverage on shares of Medidata Solutions in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $82.00 price target on the stock. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $90.00 price target (up from $75.00) on shares of Medidata Solutions in a report on Friday, July 21st. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Medidata Solutions has an average rating of “Buy” and an average target price of $83.83.
Medidata Solutions Profile
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions, Inc. (NASDAQ:MDSO).
Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.